ArticleBlood2022

Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.

Reona Sakemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.